b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31455301</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1475-2875</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>18</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Aug</Month>\n                        <Day>28</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Malaria journal</Title>\n                <ISOAbbreviation>Malar. J.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>293</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12936-019-2919-3</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Resistance to all available anti-malarial drugs has emerged and spread including artemisinin derivatives and their partner drugs. Several genes involved in artemisinin and partner drugs resistance, such as pfcrt, pfmdr1, pfK13 or pfpm2, have been identified. However, these genes do not properly explain anti-malarial drug resistance, and more particularly clinical failures observed in Africa. Mutations in genes encoding for Plasmodium falciparum proteins, such as P. falciparum Acetyl-CoA transporter (PfACT), P. falciparum UDP-galactose transporter (PfUGT) and P. falciparum cyclic amine resistance locus (PfCARL) have recently been associated to resistance to imidazolopiperazines and other unrelated drugs.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">Mutations on pfugt, pfact and pfcarl were characterized on 86 isolates collected in Dakar, Senegal and 173 samples collected from patients hospitalized in France after a travel in African countries from 2015 and 2016 to assess their potential association with ex vivo susceptibility to chloroquine, quinine, lumefantrine, monodesethylamodiaquine, mefloquine, dihydroartemisinin, artesunate, doxycycline, pyronaridine and piperaquine.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">No mutations were found on the genes pfugt and pfact. None of the pfcarl described mutations were identified in these samples from Africa. The K784N mutation was found in one sample and the K734M mutation was identified on 7.9% of all samples for pfcarl. The only significant differences in ex vivo susceptibility according to the K734M mutation were observed for pyronaridine for African isolates from imported malaria and for doxycycline for Senegalese parasites.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">No evidence was found of involvement of these genes in reduced susceptibility to standard anti-malarial drugs in African P. falciparum isolates.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Foguim</LastName>\n                    <ForeName>Francis Tsombeng</ForeName>\n                    <Initials>FT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Robert</LastName>\n                    <ForeName>Marie Gladys</ForeName>\n                    <Initials>MG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gueye</LastName>\n                    <ForeName>Mamadou Wagu\xc3\xa9</ForeName>\n                    <Initials>MW</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>F\xc3\xa9d\xc3\xa9ration des laboratoires, H\xc3\xb4pital Principal de Dakar, Dakar, Senegal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gendrot</LastName>\n                    <ForeName>Mathieu</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Diawara</LastName>\n                    <ForeName>Silman</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>F\xc3\xa9d\xc3\xa9ration des laboratoires, H\xc3\xb4pital Principal de Dakar, Dakar, Senegal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mosnier</LastName>\n                    <ForeName>Joel</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Centre national de r\xc3\xa9f\xc3\xa9rence du Paludisme, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Amalvict</LastName>\n                    <ForeName>R\xc3\xa9my</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Centre national de r\xc3\xa9f\xc3\xa9rence du Paludisme, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Benoit</LastName>\n                    <ForeName>Nicolas</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Centre national de r\xc3\xa9f\xc3\xa9rence du Paludisme, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bercion</LastName>\n                    <ForeName>Raymond</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratoire d\'analyses m\xc3\xa9dicales, Institut Pasteur de Dakar, Dakar, Senegal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fall</LastName>\n                    <ForeName>B\xc3\xa9caye</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>F\xc3\xa9d\xc3\xa9ration des laboratoires, H\xc3\xb4pital Principal de Dakar, Dakar, Senegal.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Madamet</LastName>\n                    <ForeName>Marylin</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Centre national de r\xc3\xa9f\xc3\xa9rence du Paludisme, Marseille, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pradines</LastName>\n                    <ForeName>Bruno</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unit\xc3\xa9 Parasitologie et Entomologie, D\xc3\xa9partement de Microbiologie et de maladies infectieuses, Institut de recherche biom\xc3\xa9dicale des arm\xc3\xa9es, IHU M\xc3\xa9diterran\xc3\xa9e Infection, 19-21 Boulevard Jean Moulin, 13005, Marseille, France. bruno.pradines@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRD, SSA, AP-HM, VITROME, Aix Marseille Universit\xc3\xa9, Marseille, France. bruno.pradines@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IHU M\xc3\xa9diterran\xc3\xa9e Infection, Marseille, France. bruno.pradines@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>F\xc3\xa9d\xc3\xa9ration des laboratoires, H\xc3\xb4pital Principal de Dakar, Dakar, Senegal. bruno.pradines@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Centre national de r\xc3\xa9f\xc3\xa9rence du Paludisme, Marseille, France. bruno.pradines@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <CollectiveName>French National Reference Centre for Imported Malaria Study Group</CollectiveName>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>PDH-2-NRBC-4-B-4104</GrantID>\n                    <Agency>D\xc3\xa9l\xc3\xa9gation G\xc3\xa9n\xc3\xa9rale pour l\'Armement</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>LR 607</GrantID>\n                    <Agency>Sch\xc3\xa9ma directeur paludisme Etat major des arm\xc3\xa9es</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>CNR Paludisme</GrantID>\n                    <Agency>Sant\xc3\xa9 Publique France</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>28</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Malar J</MedlineTA>\n            <NlmUniqueID>101139802</NlmUniqueID>\n            <ISSNLinking>1475-2875</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015800">Protozoan Proteins</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004351" MajorTopicYN="Y">Drug Resistance</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010963" MajorTopicYN="N">Plasmodium falciparum</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015800" MajorTopicYN="N">Protozoan Proteins</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012675" MajorTopicYN="N" Type="Geographic">Senegal</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Anti-malarial drug</Keyword>\n            <Keyword MajorTopicYN="N">In vitro</Keyword>\n            <Keyword MajorTopicYN="N">Malaria</Keyword>\n            <Keyword MajorTopicYN="N">Molecular marker</Keyword>\n            <Keyword MajorTopicYN="N">PfACT</Keyword>\n            <Keyword MajorTopicYN="N">PfCARL</Keyword>\n            <Keyword MajorTopicYN="N">PfUGT</Keyword>\n            <Keyword MajorTopicYN="N">Plasmodium falciparum</Keyword>\n            <Keyword MajorTopicYN="N">Resistance</Keyword>\n        </KeywordList>\n        <InvestigatorList>\n            <Investigator ValidYN="Y">\n                <LastName>Augis</LastName>\n                <ForeName>V</ForeName>\n                <Initials>V</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Basset</LastName>\n                <ForeName>D</ForeName>\n                <Initials>D</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Bastien</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Benoit-Vical</LastName>\n                <ForeName>F</ForeName>\n                <Initials>F</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Berry</LastName>\n                <ForeName>A</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Brouqui</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Cividin</LastName>\n                <ForeName>M</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Delaunay</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Delhaes</LastName>\n                <ForeName>L</ForeName>\n                <Initials>L</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Drancourt</LastName>\n                <ForeName>M</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Gaillard</LastName>\n                <ForeName>T</ForeName>\n                <Initials>T</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Genin</LastName>\n                <ForeName>A</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Garnotel</LastName>\n                <ForeName>E</ForeName>\n                <Initials>E</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Javelle</LastName>\n                <ForeName>E</ForeName>\n                <Initials>E</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>L\'Ollivier</LastName>\n                <ForeName>C</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Leveque</LastName>\n                <ForeName>M</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Malvy</LastName>\n                <ForeName>D</ForeName>\n                <Initials>D</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Marty</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Mechain</LastName>\n                <ForeName>M</ForeName>\n                <Initials>M</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>M\xc3\xa9nard</LastName>\n                <ForeName>G</ForeName>\n                <Initials>G</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Millet</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Minodier</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Mottard</LastName>\n                <ForeName>A</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Parola</LastName>\n                <ForeName>P</ForeName>\n                <Initials>P</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Piarroux</LastName>\n                <ForeName>R</ForeName>\n                <Initials>R</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Pomares-Estran</LastName>\n                <ForeName>C</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Receveur</LastName>\n                <ForeName>M-C</ForeName>\n                <Initials>MC</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Robin</LastName>\n                <ForeName>A</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Sappa</LastName>\n                <ForeName>E</ForeName>\n                <Initials>E</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Savini</LastName>\n                <ForeName>H</ForeName>\n                <Initials>H</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Simon</LastName>\n                <ForeName>F</ForeName>\n                <Initials>F</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Sterkers</LastName>\n                <ForeName>Y</ForeName>\n                <Initials>Y</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Surcouf</LastName>\n                <ForeName>C</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Varlet</LastName>\n                <ForeName>E</ForeName>\n                <Initials>E</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Wolff</LastName>\n                <ForeName>A</ForeName>\n                <Initials>A</Initials>\n            </Investigator>\n        </InvestigatorList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31455301</ArticleId>\n            <ArticleId IdType="doi">10.1186/s12936-019-2919-3</ArticleId>\n            <ArticleId IdType="pii">10.1186/s12936-019-2919-3</ArticleId>\n            <ArticleId IdType="pmc">PMC6712813</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Am J Trop Med Hyg. 2000 Jan;62(1):82-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10761729</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell. 2000 Oct;6(4):861-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11090624</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2001 Jun;45(6):1746-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11353621</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2004 Jul 31-Aug 6;364(9432):438-447</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15288742</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genome Biol. 2005;6(3):R26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15774027</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Microbiol. 2005 Aug;57(4):913-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16091034</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Trop Med Hyg. 2006 Jun;74(6):953-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16760503</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Trop Med Hyg. 2006 Jul;75(1):146-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16837722</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2007 Apr 16;6:44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17437625</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):181-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18165491</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2009 Mar 27;323(5922):1693-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19325107</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2009 Jul 30;361(5):455-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19641202</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Microbiol. 2010 May;48(5):1651-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20220159</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2011 Jan 14;10:8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21235757</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2011 Sep 18;10:268</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21923936</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2011 Dec 9;334(6061):1372-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22096101</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2013 Jan 24;12:34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23347727</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2014 Jan 2;505(7481):50-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24352242</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2014 Sep;58(9):5060-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24913172</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Infect Dis. 2014 Dec 15;210(12):2001-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24994911</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2014 Jul 31;371(5):411-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25075834</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2015 Jan;59(1):437-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25367912</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2015 Feb 05;14:49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25848972</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2015 Feb 06;14:60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25849097</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Infect Dis. 2015 Jun;15(6):683-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25877962</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Biophys. 2015;44:257-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26098515</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Med. 2015 Dec 22;13:305</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26695060</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2016 Jan 06;15:10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26739092</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Infect Dis. 2016 Mar;16(3):357-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26774243</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Emerg Infect Dis. 2016 May;22(5):841-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27088703</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2016 May 18;7:11553</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27189525</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Jun 23;374(25):2453-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27332904</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>MBio. 2016 Jul 05;7(4):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27381290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2016 Jul 07;15(1):347</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27387549</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2016 Sep 23;60(10):5649-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27401569</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Trop Med Hyg. 2016 Nov 2;95(5):1054-1060</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27549635</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Microbiol. 2016 Sep 19;1:16166</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27642791</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Sep 22;375(12):1152-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27653565</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Infect Dis. 2017 Feb;17(2):164-173</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27818095</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Infect Dis. 2017 Feb;17(2):174-183</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27818097</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>ACS Infect Dis. 2016 Nov 11;2(11):816-826</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27933786</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2017 Jan 13;16(1):27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28086775</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2017 Feb 23;61(3):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28137810</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2017 Feb 2;16(1):62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28153004</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2017 Mar 16;16(1):118</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28302108</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Emerg Infect Dis. 2017 Apr;23(4):715-717</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28322709</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Antimicrob Agents. 2017 Jun;49(6):754-756</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28450175</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2017 May 12;16(1):195</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28494763</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genome Biol Evol. 2017 Jun 1;9(6):1673-1686</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28854635</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2017 Nov 22;61(12):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28923866</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Infect Dis. 2017 Nov 15;216(8):1008-1017</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28968782</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2018 Aug 17;9(1):3314</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30115924</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2018 Oct 24;62(11):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30181370</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Malar J. 2018 Oct 17;17(1):369</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30333022</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12799-12804</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30420498</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2019 Apr 25;63(5):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30782997</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'